97 related articles for article (PubMed ID: 2315924)
41. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
[TBL] [Abstract][Full Text] [Related]
42. Effect of sodium butyrate on metallothionein induction and cadmium cytotoxicity in ROS 17/2.8 cells.
Thomas DJ; Angle CR; Swanson SA; Caffrey TC
Toxicology; 1991 Feb; 66(1):35-46. PubMed ID: 1996466
[TBL] [Abstract][Full Text] [Related]
43. 1,25-Dihydroxyvitamin D3 promotes vitamin K2 metabolism in human osteoblasts.
Miyake N; Hoshi K; Sano Y; Kikuchi K; Tadano K; Koshihara Y
Osteoporos Int; 2001; 12(8):680-7. PubMed ID: 11580082
[TBL] [Abstract][Full Text] [Related]
44. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.
Atkins GJ; Anderson PH; Findlay DM; Welldon KJ; Vincent C; Zannettino AC; O'Loughlin PD; Morris HA
Bone; 2007 Jun; 40(6):1517-28. PubMed ID: 17395559
[TBL] [Abstract][Full Text] [Related]
45. Insulin-like growth factor-1 modulates steroid hormone effects on osteocalcin synthesis in human MG-63 osteosarcoma cells.
Pirskanen A; Jääskeläinen T; Mäenpää PH
Eur J Biochem; 1993 Dec; 218(3):883-91. PubMed ID: 8281940
[TBL] [Abstract][Full Text] [Related]
46. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
47. Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines.
Thompson L; Wang S; Tawfik O; Templeton K; Tancabelic J; Pinson D; Anderson HC; Keighley J; Garimella R
J Orthop Res; 2012 May; 30(5):831-44. PubMed ID: 22042758
[TBL] [Abstract][Full Text] [Related]
48. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells.
Ogawa T; Tokuda M; Tomizawa K; Matsui H; Itano T; Konishi R; Nagahata S; Hatase O
Biochem Biophys Res Commun; 1998 Aug; 249(1):226-30. PubMed ID: 9705862
[TBL] [Abstract][Full Text] [Related]
49. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
50. [Effects of 1,25 dihydroxyvitamin d3 on the morphology and alkaline phosphatase activity of ROS 17/2,8 osteoblastic cells: influence of time and dose].
Chavassieux P; Boivin G; Terrier C; Serre CM; Lagarde D; Meunier PJ
Reprod Nutr Dev; 1990; 30(3):439-43. PubMed ID: 2397037
[TBL] [Abstract][Full Text] [Related]
51. Bisphosphonates inhibit 1,25-dihydroxyvitamin D3-induced increase of osteocalcin in plasma of rats in vivo and in culture medium of rat calvaria in vitro.
Stronski SA; Bettschen-Camin L; Wetterwald A; Felix R; Trechsel U; Fleisch H
Calcif Tissue Int; 1988 Apr; 42(4):248-54. PubMed ID: 2969277
[TBL] [Abstract][Full Text] [Related]
52. 1 alpha, 25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line.
Franceschi RT; James WM; Zerlauth G
J Cell Physiol; 1985 Jun; 123(3):401-9. PubMed ID: 2985632
[TBL] [Abstract][Full Text] [Related]
53. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro.
Koshihara Y; Hoshi K
J Bone Miner Res; 1997 Mar; 12(3):431-8. PubMed ID: 9076586
[TBL] [Abstract][Full Text] [Related]
54. Actions of calcipotriol (MC 903), a novel vitamin D3 analog, on human bone-derived cells: comparison with 1,25-dihydroxyvitamin D3.
Evans DB; Thavarajah M; Binderup L; Kanis JA
J Bone Miner Res; 1991 Dec; 6(12):1307-15. PubMed ID: 1792941
[TBL] [Abstract][Full Text] [Related]
55. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts.
Veenstra TD; Fahnestock M; Kumar R
Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335
[TBL] [Abstract][Full Text] [Related]
56. 1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells.
Prince CW; Butler WT
Coll Relat Res; 1987 Sep; 7(4):305-13. PubMed ID: 3478171
[TBL] [Abstract][Full Text] [Related]
57. Retinoids modify regulation of endogenous gene expression by vitamin D3 and thyroid hormone in three osteosarcoma cell lines.
Williams GR; Bland R; Sheppard MC
Endocrinology; 1995 Oct; 136(10):4304-14. PubMed ID: 7664649
[TBL] [Abstract][Full Text] [Related]
58. Regulation of metallothionein gene expression by 1 alpha,25-dihydroxyvitamin D3 in cultured cells and in mice.
Karasawa M; Hosoi J; Hashiba H; Nose K; Tohyama C; Abe E; Suda T; Kuroki T
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8810-3. PubMed ID: 3480513
[TBL] [Abstract][Full Text] [Related]
59. 1,25-Dihydroxyvitamin D3, recombinant human transforming growth factor-beta 1, and recombinant human bone morphogenetic protein-2 induce in vitro differentiation of canine osteosarcoma cells.
Nozaki K; Kadosawa T; Nishimura R; Mochizuki M; Takahashi K; Sasaki N
J Vet Med Sci; 1999 Jun; 61(6):649-56. PubMed ID: 10423687
[TBL] [Abstract][Full Text] [Related]
60. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J
Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
